In vitro antibacterial activity of curcumin-meropenem combination against extensively drug-resistant (XDR) bacteria isolated from burn wound infections

Document Type : Short communication


1 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

3 Depratment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran


Objective: Burn wound infection is a severe complication of thermal injury. Patients with severe burn injuries need urgent care to diminish complications after severe burns. Wound infections are commonly considered one of the most serious burn complications, particularly those that are caused by extensively drug-resistant (XDR) bacteria with few therapeutic choices. The objective of this study was to determine in vitro activity of meropenem and curcumin, alone and in combination, against antibiotic-susceptible Gram-positive, and antibiotic-resistant and antibiotic susceptible gram-negative bacteria isolated from burn wound infections.
Materials and Methods: The antimicrobial activity of meropenem and curcumin was investigated alone and in combination, against antibiotic-susceptible and antibiotic-resistant bacterial (XDR) strains isolated from burn patients. In addition, the cytotoxic effect of curcumin on human’s epithelial cell lines, was determined.
Results: In this study, minimum inhibitory concentrations of meropenem decreased considerably in the presence of curcumin (2- to 16-fold reductions), with synergy observed. Curcumin exerted no cytotoxic effect at concentrations 256-512 µg/ml on human epithelial cell lines.
Conclusion: We suggest that curcumin-antibiotic combinations may provide an alternative approach for treating infections with multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria.


Main Subjects

Bahramian A, Shariati A, Azimi T, Sharahi JY, Bostanghadiri N, Gachkar L, Ghalavand Z, Chirani AS, Erfanimanesh S, Hashemi A. 2019. First report of New Delhi metallo-β-lactamase-6 (NDM-6) among Klebsiella pneumoniae ST147 strains isolated from dialysis patients in Iran. Infect Genet  Evol, 23:142-145.
Bansal S, Chhibber S. 2010. Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice. J Med Microbiol, 59: 429-437.
Betts JW, Sharili AS, La Ragione RM, Wareham DW. 2016. In vitro antibacterial activity of curcumin–polymyxin B combinations against multidrug-resistant bacteria associated with traumatic wound infections. J Nat Prod, 79: 1702-1706.
Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann M-C. 2005. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci, 88: 412-419.
Chew KL, La M-V, Lin RT, Teo JW. 2017. Colistin and polymyxin B susceptibility testing for carbapenem-resistant and mcr-positive Enterobacteriaceae: comparison of Sensititre, MicroScan, Vitek 2, and Etest with broth microdilution. J Med Microbiol, 00268-00217.
Chiu S-K, Ma L, Chan M-C, Lin Y-T, Fung C-P, Wu T-L, Chuang Y-C, Lu P-L, Wang J-T, Lin J-C. 2018. Carbapenem nonsusceptible klebsiella pneumoniae in taiwan: dissemination and increasing resistance of carbapenemase producers during 2012–2015. Sci Rep, 8: 8468.
Church D, Elsayed S, Reid O, Winston B, Lindsay R. 2006. Burn wound infections. Clin Microbiol Rev, 19: 403-434.
Fallah F, Noori M, Hashemi A, Goudarzi H, Karimi A, Erfanimanesh S, Alimehr S. 2014. Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica, 2014.
Gul P, Bakht J. 2015. Antimicrobial activity of turmeric extract and its potential use in food industry. Int J Food Sci Technol, 52: 2272-2279.
Gupta SC, Patchva S, Aggarwal BB. 2013. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J, 15: 195-218.
Hewlings S, Kalman D. 2017. Curcumin: a  review of its’ effects on human health. Foods,  6: 92.
Hirsch EB, Tam VH. 2010. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes.
Expert Rev Pharmacoecon Outcomes Res, 10: 441-451.
Karaman M, Firinci F, Ayyildiz ZA, Bahar İH. 2013. Pseudomonas aeruginosa Suşlarında İmipenem, Tobramisin ve Curcuminin Biyofilm Oluşumu Üzerine Etkisi. Mikrobiyol Bul, 47: 192-194.
Kaur A, Sharma P, Capalash N. 2018. Curcumin alleviates persistence of Acinetobacter baumannii against colistin. Sci rep, 8: 11029.
Lee S, Al Razqan GS, Kwon DH. 2017. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Phytomedicine, 24: 49-55.
Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis, 16: 161-168.
McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH. 2013. Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae. Antimicrob Agents Ch, 57: 5131-5133.
Menegucci TC, Albiero J, Migliorini LB, Alves JLB, Viana GF, Mazucheli J, Carrara-Marroni FE, Cardoso CL, Tognim MCB. 2016. Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections. Int J Antimicrob Agents, 47: 380-385.
Mohammadi F, Goudarzi H, Hashemi A, Nojookambari NY, Khoshnood S, Sabzehali F. 2017. Detection of ISAba1 in Acinetobacter baumannii strains carrying OXA genes isolated from iranian burns patients. Pediatr Infect Dis J , 5-:e39307.
Suzuki S, Ohnishi M, Kawanishi M, Akiba M, Kuroda M. 2016. Investigation of a plasmid genome database for colistin-resistance gene mcr-1. Lancet Infect Dis, 16: 284-285.
Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. 2015. Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PloS one, 10: e0121313.
Wayne P. 2012. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement. Document, M100-S22